A Human Breast Cancer-Derived Xenograft and Organoid Platform for Drug Discovery and Precision Oncology

Researchers reported a bank of human patient-derived xenografts and matched organoid cultures from tumors that represented the greatest unmet need: endocrine-resistant, treatment-refractory, and metastatic breast cancers.